Star Health & Allied Insurance Company company name will host analysts and institutional investors on August 14, 2026, during the Emkay Confluence 2026 event in Mumbai. The in-person meeting is scheduled to begin at 10:00 AM IST, providing market participants with a direct channel to discuss the insurer’s strategic outlook and operational performance for FY27. This engagement follows standard disclosure practices under SEBI regulations, ensuring transparency regarding the company’s upcoming fiscal year trajectory.

The announcement was made on August 07, 2026, via intimation letters submitted to the Listing Departments of both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The disclosure complies with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jayashree Sethuraman, Company Secretary and Compliance Officer, signed off on the filing, confirming the schedule and regulatory adherence.

Meeting Details

The interaction will take place in Mumbai as part of the broader Emkay Confluence 2026 conference. Unlike virtual sessions, this format allows for real-time dialogue between management and investment professionals. The company noted that the schedule remains subject to change due to exigencies on the part of analysts or investors.

Investors interested in reviewing the company’s perspective prior to or following the session can access the presentation deck via the link provided in the exchange filing. The document is also hosted on the company’s official website, www.starhealth.in , ensuring broad accessibility for stakeholders who may not attend the physical event.

Regulatory Context

Under SEBI’s LODR regulations, listed entities are required to disclose the schedule of meetings with analysts and institutional investors promptly. This ensures that no single group of investors receives preferential information ahead of others. By publishing the details on August 07, 2026, Star Health maintains compliance with these transparency norms while preparing for its FY27 reporting cycle.

No financial results, dividend declarations, or corporate actions were announced alongside this scheduling notice. The focus remains strictly on investor relations and market communication ahead of the new fiscal year.

Star Health and Allied Insurance Company Limited reported a Profit After Tax (PAT) of ₹54,973 lakh for the quarter ended June 30, 2026 (Q1FY27), marking a 25.2% year-on-year increase from ₹43,818 lakh in Q1FY26. The Chennai-based insurer’s underwriting profit surged sixfold to ₹111 crore, compared to ₹16 crore in the previous year, driven by disciplined pricing and improved claims management. This performance underscores the company’s ability to enhance operational efficiency despite industry-wide inflationary pressures, delivering stronger core profitability insulated from investment volatility.

The Board of Directors, chaired by Managing Director and CEO Anand Roy, approved the unaudited standalone financial results on July 29, 2026. The results were reviewed by Joint Statutory Auditors M/s. T R Chadha & Co LLP and M/s. MSKA & Associates LLP under Ind AS 34. In addition to financial approvals, the Board authorized the reclassification of shareholders from the Late Rakesh Jhunjhunwala promoter group to the public category, subject to stock exchange approval. The company also confirmed the exercise of call options for 4,000 convertible debentures redeemable on September 30, 2026, and 700 debentures due on October 29, 2026.

Financial Performance Highlights

Star Health’s profitability was supported by a significant recovery in investment income, which swung to a positive ₹64,369 lakh in Q1FY27 from ₹58,644 lakh in Q1FY26. The insurance service result stood at ₹42,510 lakh, compared to ₹28,784 lakh in the previous year. Key metrics for the quarter are detailed below:

The claims ratio for general insurance business increased slightly to 67.48% from 68.52% in Q1FY26, indicating better claims experience relative to premiums earned. The combined operating ratio (CoR) improved to 90.93% from 92.00% in the prior year quarter, signaling enhanced operational efficiency. Total assets grew to ₹23,78,004 lakh, with policyholder investments constituting ₹13,89,180 lakh.

Segment-Wise Breakdown

The health insurance segment remained the primary growth engine, reporting insurance revenue of ₹4,86,790 lakh, up from ₹4,27,971 lakh in Q1FY26. Fresh Retail Health Gross Written Premium (GWP) surged 37% YoY to ₹730 crore. The personal accident segment saw a slight decline in revenue to ₹4,769 lakh from ₹5,392 lakh, while travel insurance revenue contracted to ₹161 lakh from ₹279 lakh. Despite the smaller size of these segments, they contributed marginally to the overall profit, with health accounting for ₹54,557 lakh of the total net profit.

What the Numbers Show

A notable divergence exists between the top-line growth and the claims inflation rate. While GWP grew by nearly 19%, incurred claims rose by only 12.4%, suggesting that premium pricing has outpaced claim costs in this period. Furthermore, the swing in investment income significantly boosted the bottom line, contributing to a return on equity (RoE) of 5.57% (quarterly), compared to 4.93% in the previous year. The solvency ratio remains robust at 2.09, well above regulatory requirements, providing a buffer against future volatility.

Operational Efficiency and Digital Growth

Star Health settled 9.6 lakh claims during Q1FY27, with the Retail Claims Settlement Ratio improving to 91%. Persistency improved by 3% YoY to 102%, and the Company Net Promoter Score (NPS) rose by 12 points to 65 as on June 2026. Digital channels contributed 16% of fresh retail sales, up 142% YoY, with 97% of fresh policies sourced digitally. The company’s AI-enabled platform, ATOM PRO, won “InsurTech Product Excellence of the Year” at the BFSI FinNext Awards 2026, reinforcing its technology-led distribution strategy across its network of 900+ branches and 8.5 lakh+ agents.